Index S&P 500 P/E 15.18 EPS (ttm) 21.99 Insider Own 29.12% Shs Outstand 249.98M Perf Week 1.64%
Market Cap 82.19B Forward P/E 11.94 EPS next Y 27.96 Insider Trans -0.02% Shs Float 174.51M Perf Month 5.51%
Income 5.76B PEG 1.25 EPS next Q 5.78 Inst Own 65.73% Short Float 3.38% Perf Quarter 11.60%
Sales 70.60B P/S 1.16 EPS this Y 13.25% Inst Trans 0.56% Short Ratio 3.65 Perf Half Y -17.27%
Book/sh -10.00 P/B - EPS next Y 12.42% ROA 9.95% Short Interest 5.89M Perf Year 1.51%
Cash/sh 8.21 P/C 40.67 EPS next 5Y 12.14% ROE - 52W Range 289.98 - 417.14 Perf YTD 11.22%
Dividend Est. 2.80 (0.84%) P/FCF 14.58 EPS past 5Y 16.93% ROI 15.28% 52W High -19.97% Beta 1.54
Dividend TTM 2.70 (0.81%) Quick Ratio 0.97 Sales past 5Y 6.69% Gross Margin 14.94% 52W Low 15.13% ATR (14) 9.73
Dividend Ex-Date Mar 17, 2025 Current Ratio 1.08 EPS Y/Y TTM 15.32% Oper. Margin 14.94% RSI (14) 56.79 Volatility 1.94% 3.12%
Employees 316000 Debt/Eq - Sales Y/Y TTM 8.67% Profit Margin 8.16% Recom 1.86 Target Price 379.05
Option/Short Yes / Yes LT Debt/Eq - EPS Q/Q -4.95% Payout 12.00% Rel Volume 0.88 Prev Close 328.79
Sales Surprise 0.28% EPS Surprise 1.46% Sales Q/Q 5.68% Earnings Jan 24 BMO Avg Volume 1.61M Price 333.84
SMA20 3.18% SMA50 3.79% SMA200 -3.43% Trades
Volume 1,423,792 Change 1.54%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-17-24 Resumed JP Morgan
Neutral
$380
Nov-25-24 Downgrade Wells Fargo
Equal Weight → Underweight
$400 → $320
Nov-22-24 Downgrade Raymond James
Outperform → Mkt Perform
Oct-11-24 Initiated KeyBanc Capital Markets
Overweight
$475
Sep-03-24 Initiated Morgan Stanley
Equal-Weight
$427
May-30-24 Initiated Robert W. Baird
Outperform
$396
Mar-06-24 Initiated Barclays
Overweight
$356
Jan-04-24 Downgrade Bernstein
Outperform → Mkt Perform
$277 → $301
Dec-11-23 Downgrade Goldman
Buy → Neutral
$271
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$304
Apr-19-23 Resumed JP Morgan
Neutral
$257 → $283
Jul-06-22 Downgrade BMO Capital Markets
Market Perform → Underperform
$233 → $160
Jun-17-22 Initiated Loop Capital
Buy
$240
May-27-22 Upgrade Bernstein
Mkt Perform → Outperform
$273 → $271
Mar-29-22 Initiated Wells Fargo
Equal Weight
$267
Jan-10-22 Resumed Citigroup
Buy
$274 → $306
Dec-21-21 Downgrade JP Morgan
Overweight → Neutral
$270
Sep-27-21 Initiated SVB Leerink
Outperform
$320
Sep-24-21 Initiated UBS
Buy
$312
Sep-10-21 Initiated Cowen
Outperform
$293
Show Previous Ratings
Mar-24-25 02:54PM
06:50AM
05:12AM
Mar-23-25 01:46PM
Mar-21-25 10:05AM
09:40AM
Loading…
Mar-20-25 09:40AM
09:05AM
Mar-18-25 09:50AM
09:44AM
Mar-17-25 09:00AM
08:20AM
Mar-14-25 11:24AM
Mar-13-25 08:30AM
Mar-11-25 08:30AM
Mar-08-25 08:35AM
11:10AM
Loading…
Mar-07-25 11:10AM
Mar-03-25 09:40AM
Feb-24-25 09:30AM
Feb-20-25 04:00PM
Feb-18-25 08:40AM
Feb-17-25 09:50AM
Feb-13-25 09:40AM
Feb-10-25 09:30AM
Feb-09-25 07:15AM
Feb-04-25 06:16AM
Jan-31-25 03:06PM
Jan-29-25 09:45AM
08:30AM
Jan-28-25 02:34PM
09:40AM
04:59PM
Loading…
Jan-27-25 04:59PM
Jan-25-25 02:02AM
01:15AM
(Thomson Reuters StreetEvents)
Jan-24-25 05:45PM
12:36PM
09:59AM
09:30AM
08:40AM
08:09AM
07:37AM
(Associated Press Finance)
07:30AM
Jan-20-25 09:15AM
Jan-19-25 05:00AM
Jan-17-25 10:00AM
Jan-07-25 07:57AM
Jan-06-25 06:04PM
Jan-01-25 12:47PM
Dec-28-24 04:44PM
12:11AM
Dec-27-24 08:11AM
Dec-20-24 08:30AM
Dec-04-24 08:05AM
Nov-27-24 07:00AM
(The Wall Street Journal)
Nov-25-24 08:25AM
Nov-22-24 04:04PM
Nov-20-24 08:30AM
Nov-18-24 06:50PM
Nov-14-24 08:30AM
Nov-12-24 12:31AM
Nov-11-24 08:30AM
Nov-06-24 10:34AM
(The Wall Street Journal)
10:34AM
(The Wall Street Journal)
Nov-01-24 01:04AM
Oct-29-24 04:57AM
Oct-26-24 07:57AM
03:07AM
01:06AM
(Thomson Reuters StreetEvents)
Oct-25-24 04:02PM
(Yahoo Finance Video) -8.86%
03:30PM
01:43PM
12:44PM
12:40PM
11:47AM
11:31AM
(The Wall Street Journal)
11:11AM
(The Wall Street Journal)
10:32AM
09:30AM
08:55AM
08:54AM
07:51AM
(Associated Press Finance)
07:37AM
07:30AM
Oct-24-24 09:45AM
Oct-23-24 09:40AM
Oct-22-24 09:15AM
08:30AM
Oct-19-24 09:15AM
Oct-18-24 10:00AM
Oct-17-24 05:00PM
07:41AM
Oct-16-24 06:26AM
06:26AM
Oct-15-24 11:30AM
(The Wall Street Journal)
Oct-05-24 09:24AM
Oct-04-24 12:10PM
Oct-02-24 05:26AM
Oct-01-24 02:07PM
Sep-28-24 01:21PM
Sep-26-24 04:00PM
Sep-24-24 04:30PM
HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Berres Jennifer SVP & Chief Human Res. Officer Feb 14 '25 Sale 322.59 9,533 3,075,240 15,412 Feb 18 07:28 PM Berres Jennifer Officer Feb 14 '25 Proposed Sale 322.59 9,533 3,075,238 Feb 14 04:26 PM Berres Jennifer SVP & Chief Human Res. Officer Feb 07 '25 Option Exercise 115.12 11,780 1,356,151 30,511 Feb 11 06:16 PM Reiner Deborah M Former Officer Feb 11 '25 Proposed Sale 322.39 3,510 1,131,589 Feb 11 05:07 PM Whalen Kathleen M Former Officer Jan 31 '25 Proposed Sale 335.25 3,228 1,082,203 Jan 31 04:12 PM Whalen Kathleen M SVP & Chief Ethics Officer Nov 14 '24 Sale 357.99 1,474 527,677 9,454 Nov 18 05:50 PM Foster Jon M EVP and COO Nov 14 '24 Option Exercise 101.16 36,600 3,702,456 47,180 Nov 18 05:47 PM Billington Phillip G SVP-Internal Audit Services Nov 12 '24 Option Exercise 68.96 8,000 551,680 60,702 Nov 14 06:53 PM Billington Phillip G SVP-Internal Audit Services Nov 14 '24 Sale 350.00 3,897 1,363,950 52,702 Nov 14 06:53 PM Akdamar Erol R Group President Nov 12 '24 Option Exercise 68.96 20,000 1,379,200 20,000 Nov 14 06:50 PM Akdamar Erol R Group President Nov 14 '24 Sale 353.00 2,900 1,023,700 6,843 Nov 14 06:50 PM Whalen Kathleen M Officer Nov 14 '24 Proposed Sale 357.99 1,474 527,677 Nov 14 06:20 PM Akdamar Erol R Officer Nov 14 '24 Proposed Sale 357.86 4,872 1,743,480 Nov 14 06:19 PM Billington Phillip G Officer Nov 14 '24 Proposed Sale 350.00 3,897 1,363,950 Nov 14 06:17 PM Whalen Kathleen M SVP & Chief Ethics Officer Nov 11 '24 Option Exercise 173.12 4,710 815,395 14,164 Nov 13 06:17 PM Cuffe Michael S. EVP and Chief Clinical Officer Sep 10 '24 Option Exercise 145.24 22,080 3,206,899 51,758 Sep 12 05:21 PM Cuffe Michael S. EVP and Chief Clinical Officer Sep 12 '24 Sale 385.42 8,358 3,221,340 29,678 Sep 12 05:21 PM Cuffe Michael S. Officer Sep 12 '24 Proposed Sale 385.42 8,358 3,221,340 Sep 12 05:13 PM McManus Timothy M Group President Jul 31 '24 Option Exercise 77.13 7,500 578,475 30,927 Aug 02 05:21 PM Whalen Kathleen M SVP & Chief Ethics Officer Jul 29 '24 Option Exercise 145.24 8,280 1,202,587 19,598 Jul 31 05:44 PM Whalen Kathleen M SVP & Chief Ethics Officer Jul 31 '24 Sale 363.51 2,987 1,085,804 9,454 Jul 31 05:44 PM Whalen Kathleen M SVP & Chief Ethics Officer Jul 29 '24 Sale 359.92 1,864 670,891 12,441 Jul 31 05:44 PM Reiner Deborah M SVP - Mktg. & Communications Jul 29 '24 Sale 359.96 3,314 1,192,914 3,510 Jul 31 05:12 PM Whalen Kathleen M Officer Jul 31 '24 Proposed Sale 363.51 2,987 1,085,804 Jul 31 04:15 PM Wyatt Christopher F. SVP & Controller Jul 25 '24 Option Exercise 101.16 9,300 940,788 49,727 Jul 29 05:25 PM Wyatt Christopher F. SVP & Controller Jul 29 '24 Sale 360.20 4,000 1,440,782 40,449 Jul 29 05:25 PM Torres Kathryn A. SVP-Payer Contracting & Align. Jul 25 '24 Sale 355.05 1,857 659,328 17,755 Jul 29 05:18 PM Wyatt Christopher F. Officer Jul 29 '24 Proposed Sale 360.20 4,000 1,440,783 Jul 29 04:24 PM Reiner Deborah M Officer Jul 29 '24 Proposed Sale 359.96 3,314 1,192,914 Jul 29 04:18 PM Whalen Kathleen M Officer Jul 29 '24 Proposed Sale 359.92 1,864 670,891 Jul 29 04:07 PM Whalen Kathleen M SVP & Chief Ethics Officer May 17 '24 Option Exercise 112.70 4,725 532,524 14,179 May 20 05:23 PM Whalen Kathleen M SVP & Chief Ethics Officer May 16 '24 Sale 326.30 3,204 1,045,465 9,454 May 20 05:23 PM Torres Kathryn A. SVP-Payer Contracting & Align. May 15 '24 Sale 326.18 1,863 607,673 19,612 May 17 05:14 PM Sowell Joseph A III SVP; Chief Development Officer May 15 '24 Option Exercise 68.96 19,000 1,310,240 23,275 May 17 05:13 PM Foster Jon M EVP and COO May 15 '24 Option Exercise 78.21 39,465 3,086,548 61,295 May 17 05:13 PM Cuffe Michael S. EVP and Chief Clinical Officer May 09 '24 Sale 316.88 6,311 1,999,825 29,624 May 13 05:08 PM Cohen Jeffrey E. SVP-Government Relations May 09 '24 Sale 313.00 1,650 516,450 5,185 May 13 05:07 PM Cuffe Michael S. EVP and Chief Clinical Officer May 07 '24 Option Exercise 139.06 18,660 2,594,860 52,784 May 08 05:43 PM Cuffe Michael S. EVP and Chief Clinical Officer May 06 '24 Sale 309.00 1,600 494,400 34,124 May 08 05:43 PM Torres Kathryn A. SVP-Payer Contracting & Align. May 02 '24 Sale 312.00 973 303,576 22,365 May 06 06:39 PM Torres Kathryn A. SVP-Payer Contracting & Align. May 03 '24 Sale 312.00 890 277,680 21,475 May 06 06:39 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
